Supreme Court Receives Emergency Appeal After Abortion Pill Mailing Blocked

1-Minute Brief

The Supreme Court is reviewing emergency appeals after a federal court blocked mailing prescriptions for the abortion pill mifepristone, affecting ...

Key Facts

• Danco Laboratories, the manufacturer of mifepristone, filed an emergency request to the Supreme Court following a 5th Circuit ruling.
• A federal appeals court has restricted access to mifepristone by blocking the mailing of prescriptions across the U.S.
• The court ruling reinstated in-person prescription requirements for mifepristone.
• Multiple news outlets report that the Supreme Court has been asked to restore access to abortion pills by mail.
• Danco Laboratories warned of potential 'chaos' resulting from the court's decision.

What Happened

A federal appeals court blocked the mailing of mifepristone prescriptions, prompting Danco Laboratories to file an emergency appeal to the Supreme Court to restore access.

Why It Matters

The decision impacts the availability of one of the most common abortion methods in the U.S. and raises questions about access to medication abortion nationwide.

What's Next

The Supreme Court will consider the emergency appeal, which could determine whether mifepristone can continue to be prescribed by mail or only in person.